遠大智能(002689.SZ):第三季度淨利潤預降6.84%-16.67%
格隆匯10月14日丨遠大智能(002689.SZ)公佈,預計2021年前三季度歸屬於上市公司股東的淨虧損976.84萬元-1395.49萬元,上年同期虧損1395.49萬元;其中,第三季度歸屬於上市公司股東的淨利潤3551.59萬元-3970.23萬元,同比下降6.84%-16.67%。
報吿期,公司管理層持續深化管理改革、優化管理結構、增強服務與質量管控力、推行模塊化經營,取得了一定效果,新籤合同及合同執行量均有所提升。同時,公司進一步提高運營效率與質量,優化國內外市場佈局,促進公司持續、健康發展。報吿期內歸屬於母公司股東的淨利潤較上年同期預計上升在0%-30%之間。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.